Activation of human vascular endothelial cells by factor Xa: effect of specific inhibitors.
Recently, human umbilical vein endothelial cells (HUVEC) have been shown to express functional high-affinity receptors for factor Xa, which may be of importance in the regulation of coagulation and homeostasis of the vascular wall. In this paper, we demonstrate that when added to cultured HUVEC, factor Xa was a potent mitogen, stimulating an increase in cell number at a 0.3 to 100 nM concentration. The same doses of factor Xa also increased intracellular free calcium levels and phosphoinositide turnover. When added to confluent HUVEC, factor Xa induced the expression of tissue factor and the release of tissue-type plasminogen activator and plasminogen activator inhibitor-1 without affecting urokinase expression. Indirect (antithrombin-pentasaccharide) and direct (DX9065) inhibitors of factor Xa affected all these activities of factor Xa in a dose-dependent manner. Taken together, these data show that the activities induced by factor Xa on HUVEC were dependent on its catalytic activity and could be inhibited by both direct and indirect factor Xa inhibitors.
Haemobiology Research Department, Sanofi Recherche, Toulouse, France.
J P
JP
Herault
F
F
Bono
C
C
Avril
P
P
Schaeffer
J M
JM
Herbert
D000925:Anticoagulants / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000187:drug effects*; D015951:Factor Xa / Q000494:pharmacology*; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D009281:Naphthalenes / Q000494:pharmacology; D009844:Oligosaccharides / Q000494:pharmacology; D010716:Phosphatidylinositols / Q000378:metabolism; D017395:Plasminogen Activator Inhibitor 1 / Q000096:biosynthesis; D010960:Plasminogen Activators / Q000096:biosynthesis; D011422:Propionates / Q000494:pharmacology; D013925:Thromboplastin / Q000096:biosynthesis
C086910:(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid; D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D009281:Naphthalenes; D009844:Oligosaccharides; D010716:Phosphatidylinositols; D017395:Plasminogen Activator Inhibitor 1; D011422:Propionates; C479958:idraparinux; D013925:Thromboplastin; D010960:Plasminogen Activators; D015951:Factor Xa; D002118:Calcium